Lisata Therapeutics, Inc.
NASDAQ: LSTA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David J. Mazzo
- Employees
- 26
- Headquarters
- Basking Ridge, United States
- IPO year
- 1999
- Market cap
- $31.3M
- Website
- https://www.lisata.com
Loading LSTA…
Loading profile data…Frequently asked questions about LSTA
What does Lisata Therapeutics, Inc. (LSTA) do?
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has recei...
Where does LSTA trade?
Lisata Therapeutics, Inc. (LSTA) trades on the NASDAQ Capital Market.
What sector is LSTA in?
Lisata Therapeutics, Inc. (LSTA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lisata Therapeutics, Inc.?
David J. Mazzo is the chief executive officer of Lisata Therapeutics, Inc. (LSTA).
Where is Lisata Therapeutics, Inc. headquartered?
Lisata Therapeutics, Inc. is headquartered in United States.
Does LSTA pay a dividend?
Lisata Therapeutics, Inc. (LSTA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LSTA go public?
Lisata Therapeutics, Inc. (LSTA) completed its initial public offering in 1999.